# Vor Biopharma Inc.: Form SCHEDULE 13D/A, filed Oct 16, 2025

- Company: [Vor Biopharma Inc.](/companies/vor.md) (CIK 1817229)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-16
- Accepted by EDGAR: Oct 16, 2025, 16:45 ET
- Period: not reported
- Accession: 0002050755-25-000016
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817229/000205075525000016/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817229/000205075525000016/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817229/000205075525000016/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 16, 2025.
Source: SEC EDGAR, the filing index for accession 0002050755-25-000016. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
